Numerous studies have supported the IL-6 role in prostate cancer by reporting upregulated IL-6R expression and elevated IL-6 levels in prostatic intraepithelial neoplasia (PIN) and hormone-refractory prostate cancer (Ouyang et al., 2005; Markowski et al., 2008). Here, IL6R is linked to prostate intraepithelial neoplasia.